Trial intelligence / Profile preview

Oral minoxidil 1.25 mg versus 5% topical minoxidil in female pattern hair loss

TCTR20201222005Phase 3Recruiting

Sponsor
King Chulalongkorn Memorial Hospital
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of minoxidil in androgenetic alopecia (AGA), sponsored by King Chulalongkorn Memorial Hospital. Started Jul 2021; status: recruiting.

02

Drugs

minoxidil
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on TCTR20201222005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20201222005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call